First Tracks Biotherapeutics, Inc.
TRAX
$44.04
$0.010.02%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | -33.37M | -50.48M | -42.45M | ||
| Total Depreciation and Amortization | 207.00K | 125.00K | 601.00K | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 8.47M | 11.50M | 6.06M | ||
| Change in Net Operating Assets | -7.22M | 6.30M | -2.85M | ||
| Cash from Operations | -31.92M | -32.56M | -38.64M | ||
| Capital Expenditure | -25.00K | -17.00K | -39.00K | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 0.00 | 35.00M | 36.44M | ||
| Cash from Investing | -25.00K | 34.98M | 36.40M | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 278.71M | 7.85M | -- | ||
| Repurchase of Common Stock | -- | -- | -5.72M | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -327.22M | -- | -46.39M | ||
| Cash from Financing | -48.51M | 7.85M | -52.11M | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -80.45M | 10.27M | -54.34M | ||